Safeplus International Holdings Limited (BIPH)vsResMed Inc (RMD)
BIPH
Safeplus International Holdings Limited
$15.66
+0.58%
HEALTHCARE · Cap: $357,540
RMD
ResMed Inc
$218.27
-0.60%
HEALTHCARE · Cap: $31.89B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 833827% more annual revenue ($5.65B vs $677,930). RMD leads profitability with a 27.0% profit margin vs 0.0%. RMD earns a higher WallStSmart Score of 65/100 (C+).
BIPH
Hold40
out of 100
Grade: F
RMD
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BIPH.
Margin of Safety
-24.1%
Fair Value
$209.29
Current Price
$218.27
$8.98 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
17.1% revenue growth
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 1565.5x book value
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : BIPH
The strongest argument for BIPH centers on Revenue Growth. Revenue growth of 17.1% demonstrates continued momentum.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.33 suggests the stock is reasonably priced for its growth.
Bear Case : BIPH
The primary concerns for BIPH are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 12.99 is elevated, increasing financial risk.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
BIPH profiles as a growth stock while RMD is a mature play — different risk/reward profiles.
BIPH carries more volatility with a beta of 1.04 — expect wider price swings.
BIPH is growing revenue faster at 17.1% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
RMD scores higher overall (65/100 vs 40/100), backed by strong 27.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Safeplus International Holdings Limited
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is headquartered in Pittsford, New York.
Visit Website →ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?